HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bill Directs FTC To Take Action On Photoshopped Ads

This article was originally published in The Rose Sheet

Executive Summary

A new bill presented in the House instructs the FTC to examine the use of ads that alter the physical characteristics of the face and body and develop a strategy to address the issue and reduce their use.

You may also be interested in...



L’Oreal Appeals NAD Ruling On Eyelash Enhancement

A National Advertising Division decision concerning implied and express claims in L’Oreal USA ads for mascara products reinforces the watchdog’s position on artificial enhancements to cosmetic advertising that exaggerate potential product benefits – this time focusing on physical (versus digital) alterations.

U.K. Ad Regulator Tackles Issue Of Misleading “Touch-Ups” In Beauty Ads

An advertising watchdog group in the U.K. is putting forth guidelines intended to quash the use of digital touch-ups and other techniques that exaggerate the effects of cosmetic products and mislead consumers.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018990

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel